Martinsried-based autoimmune specialist Immunic AG secured financial support for the next 3.5 years from lead...
Up To Date
Latest News
Backed by MPM Capital and Sofinnova, immuno-oncology specialist iOmx Therapeutics has raised €40m in its first...
German immuno-oncology play BioNTech has entered into a collaboration with Roche’s Genentech to develop novel...
Prexton Therapeutics is taking aim at Phase II: The Swiss company happily presented results for its Phase I...
Denmark’s Novozymes has acquired microbial research company Organobalance GmbH. The German company owns a...
14.09.2016 - The summer slump on the stock markets is over: AC Immune has confidently priced its long-awaited...
Share
